EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter trial of plasma-derived activated protein C concentrate in patients with venous thrombosis associated with inherited protein C deficiency



Multicenter trial of plasma-derived activated protein C concentrate in patients with venous thrombosis associated with inherited protein C deficiency



Blood 94(10 SUPPL 1 PART 1): 28a, Nov 15




(PDF 0-2 workdays service: $29.90)

Accession: 035349963

Download citation: RISBibTeXText



Related references

Treatment of inherited protein C deficiency by replacement therapy with the French purified plasma-derived protein C concentrate (PROTEXEL). Vox Sanguinis 93(3): 233-240, 2007

Activated protein c resistance (APC) and inherited factor V (FV) mis-sense mutation in patients with venous and arterial thrombosis in a haematology clinic. Australian and New Zealand Journal of Medicine 25(2): 151-154, 1995

Activated protein c resistance and inherited factor V mis-sense mutation in patients with venous and arterial thrombosis in a haematology clinic. Australian & New Zealand Journal of Medicine 25(2): 151-154, 1995

Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study. Arteriosclerosis, Thrombosis, and Vascular Biology 19(4): 1026-1033, 1999

Resistance to activated protein C: a common inherited cause of venous thrombosis. Annals of Vascular Surgery 10(2): 174-177, 1996

Complexes between activated protein C and protein C inhibitor in blood plasma Increased levels of complexes in patients with deep venous thrombosis. Blood 96(11 Part 1): 272a, November 16, 2000

Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S. Thrombosis and Haemostasis 71(1): 15-18, 1994

Combined protein C deficiency and protein C activated resistance as a cause of caval, peripheral, and cerebral venous thrombosis--a case report. Angiology 49(5): 399-401, 1998

Postpartum cerebral venous thrombosis, congenital protein C deficiency, and activated protein C resistance due to heterozygous factor V Leiden mutation. Journal of Neurology, Neurosurgery, and Psychiatry 65(5): 801-802, 1998

Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet (North American Edition) 343(8912): 1536-1538, 1994

Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene. Haemostasis 24(2): 139-151, 1994

Association of protein S p.Pro667Pro dimorphism with plasma protein S levels in normal individuals and patients with inherited protein S deficiency. Thrombosis Research 120(3): 421-426, 2006